Literature DB >> 22689259

[Therapy of atrial fibrillation in the critically ill].

T Willich1, M Hammwöhner, A Goette.   

Abstract

Atrial fibrillation (AF) is the most common form of arrhythmia in the intensive care unit (ICU) and is associated with increased mortality. A total of five types of AF can be distinguished: initially diagnosed, paroxysmal, persistent, long-standing persistent and permanent AF. In addition to the initial treatment, antithrombotic therapy, rate and rhythm management can be used. The treatment of comorbidities is part of the patient management and for patients with increased risk of thromboembolic events anticoagulation is recommended. The simplest risk assessment scheme is the CHADS score. In the acute setting rate control is important. Direct current cardioversion is urgently recommended for patients with AF when hemodynamic instability is present even in patients with AF and pre-excitation in Wolff-Parkinson-White syndrome. Pharmacological cardioversion may be considered in patients with AF when hemodynamic stability is present. When choosing the antiarrhythmic agent for critically ill patients only amiodarone can be considered with some exceptions due to the specific contraindications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689259     DOI: 10.1007/s00063-012-0082-5

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  23 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

Review 2.  Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.

Authors:  Robert L McNamara; Leonardo J Tamariz; Jodi B Segal; Eric B Bass
Journal:  Ann Intern Med       Date:  2003-12-16       Impact factor: 25.391

3.  A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.

Authors:  Jean-Yves Le Heuzey; Gaetano M De Ferrari; David Radzik; Massimo Santini; Junren Zhu; Jean-Marc Davy
Journal:  J Cardiovasc Electrophysiol       Date:  2010-04-06

4.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

5.  Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.

Authors:  F J Martínez-Marcos; J L García-Garmendia; A Ortega-Carpio; J M Fernández-Gómez; J M Santos; C Camacho
Journal:  Am J Cardiol       Date:  2000-11-01       Impact factor: 2.778

6.  Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks.

Authors:  Johann Reisinger; Christine Gstrein; Thomas Winter; Eduard Zeindlhofer; Kurt Höllinger; Michael Mori; Alexandra Schiller; Andreas Winter; Helmut Geiger; Peter Siostrzonek
Journal:  Am J Emerg Med       Date:  2010-02       Impact factor: 2.469

7.  Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.

Authors:  Leif Friberg; Niklas Hammar; Mårten Rosenqvist
Journal:  Eur Heart J       Date:  2009-01-27       Impact factor: 29.983

Review 8.  Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data.

Authors:  Michael Hughes; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

9.  A randomized trial comparing monophasic and biphasic waveform shocks for external cardioversion of atrial fibrillation.

Authors:  Rudolph W Koster; Paul Dorian; Fred W Chapman; Paul W Schmitt; Sharon G O'Grady; Robert G Walker
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749

Review 10.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Authors:  C Lafuente-Lafuente; S Mouly; M A Longas-Tejero; J F Bergmann
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
View more
  2 in total

1.  [Hypothermia-induced ECG changes: characteristic, but not specific].

Authors:  G Michels; S Ney; F Hoffmann; J Brugada; R Pfister; K Brockmeier; A Sultan
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-11-14       Impact factor: 0.840

Review 2.  [Atrial fibrillation on the intensive care unit : The special prognostic importance of the first manifestation].

Authors:  Andreas Goette; Sybille Brandner
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2022-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.